产品名称
Parteck®口腔崩解片, EMPROVE® ESSENTIAL
product line
EMPROVE® ESSENTIAL
form
fine powder
particle size
80-220 μm (d50)
application(s)
pharmaceutical
solid formulation
storage temp.
2-30°C
Quality Level
Application
Features and Benefits
- Robust tablets at low compression forces
- Rapid disintegration and dissolution
- No license payments
- High dilution potential – up to 50% load of your API
- Tablets with PARTECK® ODT excipient system are suitable for conventional coating
General description
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Legal Information
存储类别
11 - Combustible Solids
wgk
WGK 1
商品
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.
This article describes the use of excipients to help address API stability issues.
相关内容
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持